Study of Botulinum Toxin in Patients With Primary Hyperhidrosis

Completed · Not applicable

Conditions studied: Hyperhidrosis

In brief

OBJECTIVES: I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.

Key facts

Study ID

NCT00004480

Run by

Icahn School of Medicine at Mount Sinai

Starts

1999-07-01

Last updated by the study team

2005-06-24

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mount Sinai School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.